A correlation between the low expression of CD62P, CD63 and the fibrinogen receptor and the high risk for haemorrhage in the next 7 days of follow up for AML patients was reported recently in platelets stimulated by TRAP. This evidence concerns the gene CD63 and acute myeloid leukemia.